Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Gains from Sales and Divestitures (2023 - 2025)

Dna X filings provide 3 years of Gains from Sales and Divestitures readings, the most recent being $42956.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 25.45% to $42956.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $42956.0, a 25.45% decrease, with the full-year FY2025 number at $42956.0, down 25.45% from a year prior.
  • Gains from Sales and Divestitures hit $42956.0 in Q4 2025 for Dna X, roughly flat from $42956.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $773960.0 in Q2 2025 to a low of $2149.0 in Q1 2025.
  • Median Gains from Sales and Divestitures over the past 3 years was $45442.5 (2024), compared with a mean of $225039.9.
  • Biggest five-year swings in Gains from Sales and Divestitures: tumbled 92.08% in 2024 and later soared 1907.94% in 2025.
  • Dna X's Gains from Sales and Divestitures stood at $619042.0 in 2023, then tumbled by 90.69% to $57621.0 in 2024, then decreased by 25.45% to $42956.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $42956.0 (Q4 2025), $42956.0 (Q3 2025), and $773960.0 (Q2 2025) per Business Quant data.